Paul Magreta has over 20 years of experience in the design, start-up and operation of biopharmaceutical manufacturing facilities, and is currently responsible for developing the recombinant protein CDMO business at Grifols in Emeryville, California. Prior to Grifols, Paul led Global Process Engineering at Novartis Vaccines and Diagnostics, and had previously worked in Process Development, Manufacturing Sciences and Technology, and Process Engineering at Genentech. He has a B.S. in chemical engineering from the University of Michigan.
.svg)
